Who We Are
Who We Are
Caplin Steriles USA Inc is the wholly owned subsidiary of Caplin Steriles Ltd India

Caplin Steriles USA Inc. is the latest courageous venture by Caplin Point Laboratories Ltd. and its storied history of taking the road less traveled to fulfill the healthcare needs of the underserved.
We are a wholly owned subsidiary of Caplin Steriles Ltd. India and we operate as their sales and marketing arm concentrated on the U.S market. Caplin Steriles is an R&D driven company focused on the development and manufacturing of high quality injectables and ophthalmic products for regulated markets.
We are a part of Caplin Point Laboratories Ltd., the only mid-sized company in India’s pharmaceutical sector that is engaged in R&D and manufacturing of finished formulations, APIs and clinical research, with a dominant presence in Latin America and with brand marketing in Francophone Africa.
The company has been consistently investing in adding new plants, expanding capacity, securing quality and authentic manufacturing partnerships and fueling product portfolio expansion and diversification. Caplin’s manufacturing facilities are accredited by the US FDA, EU-GMP, INVIMA, WHO-GMP and ANVISA.
We have been in the healthcare sector since 1990
Caplin Steriles USA Inc is the wholly owned subsidiary of Caplin Steriles Ltd India
Caplin Steriles USA Inc. is the latest courageous venture by Caplin Point Laboratories Ltd. and its storied history of taking the road less traveled to fulfill the healthcare needs of the underserved.
We are a wholly owned subsidiary of Caplin Steriles Ltd. India and we operate as their sales and marketing arm concentrated on the U.S market. Caplin Steriles is an R&D driven company focused on the development and manufacturing of high quality injectables and ophthalmic products for regulated markets.
We are a part of Caplin Point Laboratories Ltd., the only mid-sized company in India’s pharmaceutical sector that is engaged in R&D and manufacturing of finished formulations, APIs and clinical research, with a dominant presence in Latin America and with brand marketing in Francophone Africa.
The company has been consistently investing in adding new plants, expanding capacity, securing quality and authentic manufacturing partnerships and fueling product portfolio expansion and diversification. Caplin’s manufacturing facilities are accredited by the US FDA, EU-GMP, INVIMA, WHO-GMP and ANVISA.
We have been in the healthcare sector since 1990
Caplin Point was established in 1990 by Mr. C.C. Paarthipan, the company’s current Chairman, and in 1994 became a publicly traded company in India. Established with the initial purpose of manufacturing ointments, creams and other external applications, the Company has expanded its product portfolio, global market reach and production capabilities.
Regulatory Approvals





